FTSE 100
|
9 230,51
|
2,40
|
0,03 %
|
Analysen zu FTSE 100-Werten
| 30.04.24 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 30.04.24 | HSBC Holdings Buy | Goldman Sachs Group Inc. | |
| 29.04.24 | National Grid Outperform | RBC Capital Markets | |
| 29.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.04.24 | Diageo Sell | UBS AG | |
| 29.04.24 | GSK Buy | UBS AG | |
| 29.04.24 | Unilever Overweight | Barclays Capital | |
| 26.04.24 | AstraZeneca Halten | DZ BANK | |
| 26.04.24 | AstraZeneca Sell | UBS AG | |
| 26.04.24 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 26.04.24 | Unilever Sell | UBS AG | |
| 26.04.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 26.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 25.04.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 25.04.24 | Unilever Sector Perform | RBC Capital Markets | |
| 25.04.24 | RELX Buy | Goldman Sachs Group Inc. | |
| 25.04.24 | Unilever Underperform | Jefferies & Company Inc. | |
| 25.04.24 | Reckitt Benckiser Neutral | Goldman Sachs Group Inc. | |
| 25.04.24 | AstraZeneca Sell | UBS AG | |
| 25.04.24 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 25.04.24 | Unilever Buy | Deutsche Bank AG | |
| 25.04.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 25.04.24 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 25.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.04.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 25.04.24 | Reckitt Benckiser Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.04.24 | Barclays Buy | UBS AG | |
| 25.04.24 | Reckitt Benckiser Overweight | Barclays Capital | |
| 25.04.24 | RELX Buy | UBS AG | |
| 25.04.24 | Barclays Outperform | RBC Capital Markets | |
| 25.04.24 | Unilever Sector Perform | RBC Capital Markets | |
| 24.04.24 | Unilever Sell | UBS AG | |
| 24.04.24 | Unilever Overweight | Barclays Capital | |
| 24.04.24 | BAT Neutral | UBS AG | |
| 24.04.24 | Reckitt Benckiser Neutral | Goldman Sachs Group Inc. | |
| 24.04.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 24.04.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | easyJet Overweight | JP Morgan Chase & Co. | |
| 24.04.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 24.04.24 | GSK Underweight | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
| AstraZeneca | 4 |
| Rolls-Royce | 2 |
| Diageo | 2 |
| GSK | 2 |
| easyJet | 2 |
| BAT | 1 |
| Reckitt Benckiser | 1 |
| Unilever | 1 |
| International Consolidated Airlines | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.